Scilit logo
  • Rankings
  • Search Publications
    Cited-by Search
  • Sources
  • Publishers
  • Scholars
    Top Cited Scholars
  • Organizations
  • Scilit
    About Us
    Advisory Board
    Data Sources
    Career
    Support / Contact
    User Guide
    Publisher User
    Search Function
    Rankings Function
    API Resource
    Scilit Knowledge
    Metrics
    Scilit Recognitions
    Publications Classification
    Media
    News
    Blog
Register
  1. Home
  2. Publications
  3. Table 2 from A Phase IB Study of Binimetinib and Palbociclib in Molecularly Selected Advanced Triple-Negative Breast Cancer
  1. Home
  2. Publications
  3. Table 2 from A Phase IB Study of Binimetinib and Palbociclib in Molecularly Selected Advanced Triple-Negative Breast Cancer

Table 2 from A Phase IB Study of Binimetinib and Palbociclib in Molecularly Selected Advanced Triple-Negative Breast Cancer

Authors:
  • LMLuis Manso
    Luis Manso
  • RSRodrigo Sánchez-Bayona
    Rodrigo Sánchez-Bayona
  • JGJuan Antonio Guerra
    Juan Antonio Guerra
  • ACAlfonso Cortés-Salgado
    Alfonso Cortés-Salgado
  • JCJuan Miguel Cejalvo
    Juan Miguel Cejalvo
  • JGJosé A. García-Saenz
    José A. García-Saenz
  • SMSerafín Morales
    Serafín Morales
  • LGLucía González-Cortijo
    Lucía González-Cortijo
  • SMSilvana Mourón
    Silvana Mourón
  • MBMaría J. Bueno
    María J. Bueno
  • LGLeonardo D. Garma
    Leonardo D. Garma
  • MQMiguel Quintela-Fandino
    Miguel Quintela-Fandino

Open Access
Publisher website
Google Scholar
  • 29 September 2025
    • other
    • Published by American Association for Cancer Research (AACR)
    • DOI:10.1158/2767-9764.30233481
Abstract
Adverse events grade 2 or higher attributed to palbociclib and binimetinib (>5% of the patients).
Keywords
  • MOLECULARLY SELECTED
  • SELECTED ADVANCED
  • BREAST CANCER
  • CANCER ADVERSE
  • ADVANCED TRIPLE-NEGATIVE
  • TRIPLE-NEGATIVE BREAST
  • ADVERSE EVENTS
  • EVENTS GRADE
  • HIGHER ATTRIBUTED
  • TABLE
Scilit logo

Have questions? Email us at support@scilit.com

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.

MDPI initiatives

  • MDPI Journals
  • MDPI Books
  • Sciforum
  • Proceedings Series
  • Preprints.org
  • SciProfiles
  • Encyclopedia
  • JAMS

Legal

  • Privacy
  • Terms
  • About
  • Contact
  • Disclaimer

Follow us

  • facebook icon
  • x icon
  • linkedin icon

Join us

  • Career

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.